Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Total Valuation
GoodRx Holdings has a market cap or net worth of $1.72B. The enterprise value is $1.88B.
Market Cap$1.72B
Enterprise Value$1.88B
Share Statistics
GoodRx Holdings has 106.74M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding106.74M
Owned by Insiders11.18%
Owned by Instutions0.44%
Financial Efficiency
GoodRx Holdings’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.69%.
Return on Equity (ROE)2.26%
Return on Assets (ROA)1.18%
Return on Invested Capital (ROIC)2.69%
Return on Capital Employed (ROCE)5.21%
Revenue Per Employee$1,073,609.756
Profits Per Employee$33,447.156
Employee Count738
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GoodRx Holdings is 109.44. GoodRx Holdings’s PEG ratio is -0.17.
PE Ratio109.44
PS Ratio2.26
PB Ratio2.48
Price to Fair Value2.48
Price to FCF11.00K
Price to Operating Cash Flow11.00K
PEG Ratio-0.17
Income Statement
In the last 12 months, GoodRx Holdings had revenue of $792.32M and earned $24.68M in profits. Earnings per share was $0.09.
Revenue$792.32M
Gross Profit$711.20M
Operating Income$79.64M
Pretax Income$31.46M
Net Income$24.68M
EBITDA153.03M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was $183.89M and capital expenditures -$70.35M, giving a free cash flow of $113.55M billion.
Operating Cash Flow$183.89M
Free Cash Flow$113.55M
Free Cash Flow per Share$1.06
Dividends & Yields
GoodRx Holdings pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield<0.01%
Earnings Yield0.91%
Stock Price Statistics
Beta1.07
52-Week Price Change-33.43%
50-Day Moving Average4.64
200-Day Moving Average5.92
Relative Strength Index (RSI)49.94
Average Volume (3m)1.49M
Important Dates
GoodRx Holdings upcoming earnings date is May 7, 2025, After Close.
Last Earnings DateFeb 27, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
GoodRx Holdings as a current ratio of 5.32, with Debt / Equity ratio of 0.08
Current Ratio5.32
Quick Ratio5.32
Debt to Market Cap0.03
Net Debt to EBITDA-2.54
Interest Coverage Ratio1.24
Taxes
In the past 12 months, GoodRx Holdings has paid $15.07M in taxes.
Income Tax$15.07M
Effective Tax Rate47.90%
Enterprise Valuation
GoodRx Holdings EV to EBITDA ratio is 9.11, with an EV/FCF ratio of 8.60K.
EV to Sales1.77
EV to EBITDA9.11
EV to Free Cash Flow8.60K
EV to Operating Cash Flow8.60K
Balance Sheet
GoodRx Holdings has $448.35M in cash and marketable securities with $56.68M in debt, giving a net cash position of -$391.67M billion.
Cash & Marketable Securities$448.35M
Total Debt$56.68M
Net Cash-$391.67M
Net Cash Per Share-$3.67
Tangible Book Value Per Share$0.68
Margins
Gross margin is 93.91%, with operating margin of 8.31%, and net profit margin of 2.07%.
Gross Margin93.91%
Operating Margin8.31%
Pretax Margin3.97%
Net Profit Margin2.07%
EBITDA Margin19.43%
EBIT Margin10.65%
Analyst Forecast
The average price target for GoodRx Holdings is $6.56, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.56
Price Target Upside46.43%
Analyst ConsensusModerate Buy
Analyst Count10
Revenue Growth Forecast5.61%
EPS Growth Forecast